Werewolf Therapeutics, Inc.HOWLNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank20
3Y CAGR-15.3%
5Y CAGR-55.0%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
-15.3%/yr
Annual compound
5Y CAGR
-55.0%/yr
Recent acceleration
Percentile
P20
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
20240.87-29.3%
20231.24+155.4%
20220.48-66.4%
20211.44-72.2%
20205.17-89.1%
201947.24-